跳至主要内容
临床试验/NL-OMON50533
NL-OMON50533已完成2 期

A randomised, double-blind, controlled trial to evaluate the effects of a new human milk fortifier on growth and tolerance in preterm infants. - Renoir

utricia Research0 个研究点目标入组 75 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 至 11(—)

入选标准

  • 1. Preterm infants fed own mother*s milk (or donor human milk) in need of a HMF
  • (as decided by the investigator)
  • 2. Gestational age <32 weeks and birth weight <1500 g
  • 3. Receiving enteral feeding
  • 4. Expected to be in need of a HMF for minimally 21 days
  • 5. Written informed consent from custodial parent(s)

排除标准

  • 1. Any relevant proven or suspected chromosomal anomaly, metabolic disorder,
  • genetic syndrome or congenital central nervous system malformation
  • 2. Presence or history of any gastrointestinal malformation/compromise,
  • including Necrotising enterocolitis (NEC) (defined as Bell*s stage two or

研究者

发起方
utricia Research

相似试验